ResMed Inc (RMD)
NYSE · Healthcare · Medical Instruments & Supplies
ResMed Inc is a Healthcare company with a market capitalization of $31.68B, a trailing P/E ratio of 20.9, and a dividend yield of 1.06%.
5-Year Price History
Latest Annual Financials · FY ending June 30, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q3 2026 | April 30, 2026 | $2.86 | $2.80 | +2.1% |
| Q2 2026 | January 29, 2026 | $2.81 | $2.72 | +3.3% |
| Q1 2026 | October 30, 2025 | $2.55 | $2.50 | +2.0% |
| Q4 2025 | July 31, 2025 | $2.55 | $2.48 | +2.8% |
| Q3 2025 | April 23, 2025 | $2.37 | $2.36 | +0.4% |
| Q2 2025 | January 30, 2025 | $2.43 | $2.31 | +5.2% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 13,541,103 | 9.21% | 7.8 | -10.3% |
| June 30, 2026 | 15,104,487 | 10.27% | 8.5 | +16.9% |
| June 15, 2026 | 12,915,210 | 8.78% | 9.0 | +8.7% |
| May 29, 2026 | 11,881,847 | 8.08% | 7.3 | -12.5% |
| May 15, 2026 | 13,573,617 | 9.23% | 8.4 | +10.4% |
| April 30, 2026 | 12,298,239 | 8.36% | 10.3 | +7.0% |
| April 15, 2026 | 11,494,456 | 7.82% | 12.7 | -3.3% |
| March 31, 2026 | 11,889,620 | 8.09% | 11.1 | +0.4% |
Other Medical Instruments & Supplies Stocks
Frequently Asked Questions
What is ResMed Inc's market cap?
As of August 13, 2026, ResMed Inc (RMD) has a market capitalization of $31.68B.
What is ResMed Inc's P/E ratio?
ResMed Inc trades at a trailing price-to-earnings (P/E) ratio of 20.9. Its forward P/E is 18.7.
Does ResMed Inc pay a dividend?
Yes — ResMed Inc pays a dividend yielding 1.06%, an annual payout of $2.40 per share.
What sector is RMD in?
ResMed Inc is in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
What is ResMed Inc's short interest?
As of the July 15, 2026 FINRA settlement, 13,541,103 RMD shares were sold short, or 9.21% of shares outstanding. Days to cover: 7.8. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was ResMed Inc's revenue?
In its latest reported fiscal year (ending June 30, 2025), ResMed Inc reported revenue of $5.15B and net income of $1.40B.
Ask your own questions about RMD
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.